Want to save up to 80% on your medications? Signup below to be notified if we open a Canadian Online Pharmacy.
Sign up to be notified if that changes.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Mounjaro (tirzepatide) is an injectable medication used to treat type 2 diabetes in adults. It is used with diet and exercise.
Patients who have had pancreatitis have not been studied while using Mounjaro.
Patients with type 1 diabetes should not use Mounjaro.
Fact Table | |
Formula |
C225H348N48O68 |
License |
US FDA |
Bioavailability |
80% |
Legal status |
Rx-Only |
Chemical Name |
Tirzepatide |
Elimination half-life |
Five days |
Dosage (Strength) |
- |
Pregnancy |
Insufficient data |
Brands |
Mounjaro |
Protein binding |
Albumin |
PubChem CID |
156588324 |
MedlinePlus |
a622044 |
ChEBI |
- |
ATC code |
- |
DrugBank |
DB15171 |
KEGG |
D11360 |
Routes of administration |
Subcutaneous |
Mounjaro comes in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL single-use injectable pens.
The instructions that come with your Mounjaro prescription should be followed. If you have any questions or concerns, talk to your pharmacist or doctor.
Mounjaro should only be used as instructed by your doctor.
Inject Mounjaro under the skin of the abdomen, thigh, or upper arm. Switch injection sites with each use.
Mounjaro Dosage:
The recommended starting dose consists of the following: inject 2.5 mg subcutaneously once a week with or without food. After 4 weeks of treatment, increase to 5 mg subcutaneously one time a week. The dosage may be increased by 2.5 mg increments at 4-week intervals depending on medication response. Dosing should not exceed 15 mg one time a week.
Tirzepatide, a glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist, is contained in Mounjaro.
If you or your family has a history of a type of thyroid cancer known as medullary thyroid carcinoma or if you have Multiple Endocrine Neoplasia syndrome type 2, you should not use Mounjaro.
If you have an allergy to tirzepatide or any of the other ingredients or excipients contained in Mounjaro, avoid treatment with Mounjaro.
WARNING: RISK OF THYROID C-CELL TUMORS
|
WARNING: RISK OF THYROID C-CELL TUMORS See full prescribing information for complete boxed warning.
|
Nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain are the most common side effects associated with Mounjaro.
Immediately call your doctor if you experience bothersome or persistent side effects.
Mounjaro- tirzepatide injection, solution. Eli Lilly and Company; 2022.